Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Br J Pharmacol ; 141(7): 1151-8, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15006902

ABSTRACT

1. beta-Adrenoceptor (beta-AR)-mediated vasodilation, which plays an important physiological role in the regulation of vascular tone, is decreased in two-kidney, one clip (2K-1C) renal hypertension. In this study, downstream pathways related to vascular beta-AR activation were evaluated in 2K-1C rats. 2. Relaxation responses to isoprenaline, forskolin and 8-Br-cAMP were diminished in aortas without endothelium from 2K-1C when compared to those in normotensive two kidney (2K). Basal adenosine-3',5'-monophosphate (cAMP), as well as isoprenaline-induced increase in cAMP levels, was not different between 2K and 2K-1C aortas. 3. Contractile responses to caffeine, after depletion and reloading of intracellular Ca(2+) stores, were greater in 2K-1C than in 2K. The presence of isoprenaline during the Ca(2+)-reloading period abolished the differences between groups by increasing caffeine contraction in 2K without changing this response in 2K-1C aortas. Inhibition of the sarcolemmal Ca(2+)ATPase with thapsigargin markedly attenuated isoprenaline vasodilation in both 2K and 2K-1C and abolished the differences between groups. 4. Blockade of ATP-sensitive K(+) channels (K(ATP)) channels with glibenclamide significantly decreased isoprenaline vasodilation in 2K-1C without affecting this response in 2K. Both vascular gene and protein expression of protein kinase A (PKA), as well as phosphoserine-containing proteins, were increased in 2K-1C vs 2K rats. 5. In conclusion, decreased isoprenaline vasodilation in 2K-1C hypertensive rats is related to impaired modulation of the sarcolemmal Ca(2+)ATPase activity. Moreover, K(ATP) channels may play a compensatory role on isoprenaline-induced relaxation in renal hypertension. Both Ca(2+)ATPase and K(ATP) channel functional alterations, associated with decreased beta-AR vasodilation, are paralleled by an upregulation of protein kinase A (PKA) and phosphoserine proteins expression.


Subject(s)
Disease Models, Animal , Hypertension, Renovascular/physiopathology , Muscle, Smooth, Vascular/physiology , Receptors, Adrenergic, beta/physiology , Signal Transduction/physiology , 8-Bromo Cyclic Adenosine Monophosphate/pharmacology , Animals , Aorta, Thoracic/chemistry , Aorta, Thoracic/drug effects , Aorta, Thoracic/pathology , Caffeine/pharmacology , Calcium-Transporting ATPases/drug effects , Calcium-Transporting ATPases/metabolism , Colforsin/pharmacology , Cyclic AMP/chemistry , Cyclic AMP/metabolism , Cyclic AMP-Dependent Protein Kinases/genetics , Cyclic AMP-Dependent Protein Kinases/metabolism , Gene Expression/drug effects , Glyburide/pharmacology , Isoproterenol/antagonists & inhibitors , Isoproterenol/pharmacology , Kidney/surgery , Male , Membrane Proteins/drug effects , Membrane Proteins/physiology , Muscle, Smooth, Vascular/chemistry , Muscle, Smooth, Vascular/drug effects , Phenylephrine/pharmacology , Potassium Channels , RNA, Messenger , Rats , Rats, Wistar , Receptors, Adrenergic, beta/drug effects , Sarcolemma/drug effects , Sarcolemma/enzymology , Signal Transduction/drug effects , Thapsigargin/pharmacology , Vasoconstriction/drug effects , Vasodilation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL